{"id":"F2005L02171","name":"Therapeutic Goods (Listing) Notice 2005 (No. 5)","slug":"therapeutic-goods-listing-notice-2005-no-5","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":36457,"registerId":"commonwealth-F2005L02171-current","compilationNumber":null,"startDate":"2026-04-01","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2005 (No. 5)","content":"![](image.001.png)\n\nTherapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2005 (No. 5)\n\nI, TERRY SLATER, National Manager, Therapeutic Goods Administration, delegate of the Minister for Health and Ageing for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods for listed goods:\n\n-   preparations, referred to in Item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations 1990, that contain, as their therapeutically active ingredient, any one of the following substances:\n\n\\- citric acid anhydrous\n\n\\- citric acid monohydrate\n\nbeing substances that are to be mentioned in Division 1 of Part 5 of Schedule 4 of the Therapeutic Goods Regulations 1990.\n\nThis Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nDated this 29th day of July 2005\n\nTerry Slater\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":806},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The notice performs exactly the limited technical function described in its title and authority—listing specific citric acid preparations in the ARTG. There is no evidence of scope creep beyond the original regulatory purpose of updating the medicines register."},"complexity_factors":["Single operative provision covering only two specific chemical substances","No conditional logic, exceptions, or procedural requirements","Short length (approximately 200 words)","Straightforward delegation chain (Minister → TGA National Manager)","Simple cross-reference to existing regulations (Schedule 4 of the Therapeutic Goods Regulations 1990)"],"plain_english_summary":"This notice approves specific over-the-counter medicines containing citric acid to be sold in Australia. **What it does:** It adds preparations containing **citric acid anhydrous** or **citric acid monohydrate** (as the main active ingredient) to the Australian Register of Therapeutic Goods (ARTG) as \"listed\" medicines. \n\n**What this means:** \n- **Listed medicines** are low-risk products like antacids, cough medicines, or vitamin supplements that don't need a doctor's prescription\n- These citric acid preparations are typically used as urinary alkalinisers (to make urine less acidic) or antacids\n- Once listed, these products can be legally supplied in Australia, though they must meet safety and manufacturing standards\n\n**Who it affects:** Manufacturers and suppliers of citric acid-based therapeutic goods who wanted to sell these products in Australia."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2005-no-5","history":"/api/acts/therapeutic-goods-listing-notice-2005-no-5/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2005-no-5/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2005-no-5/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2005-no-5/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2005-no-5/documents"}}